Roche And Innovent Kick Off 2025 With ADC Lung Cancer Deal
The Swiss giant has made a New Year’s resolution to follow up its small cell lung cancer leader Tecentriq with an antibody drug conjugate.
The Swiss giant has made a New Year’s resolution to follow up its small cell lung cancer leader Tecentriq with an antibody drug conjugate.